Content about Generics

November 29, 2010
Walgreens' Pegus to discuss impact of diabetes management on healthcare costs

Walgreens' chief medical officer will discuss the evidence-based medicine design and impact of a diabetes management program delivered by pharmacists at both workplace and community pharmacies during an upcoming conference, the drug store chain said.

November 24, 2010
Antiviral drugs could cause insulin resistance, study finds

Since the beginning of the HIV/AIDS epidemic in the early 1980s, one of the greatest advances has been antiviral drugs that have helped extend the lives of patients with viral infections.

November 24, 2010
Study: Depression may be both a risk factor and consequence of diabetes

A new study published in the Nov. 22 issue of Archives of Internal Medicine suggested there is a two-way relationship between depression and diabetes.

November 24, 2010
UnitedHealthcare partners with Kroger, Safeway on $2 generic Part D plan

UnitedHealth Group will start a program next year that it said can reduce drug costs to as low as $2 per script, the company said Tuesday.

November 22, 2010
Dr. Reddy's to buy GSK's penicillin site

A generic drug maker has entered an agreement to purchase another drug maker's U.S. penicillin site ...

November 22, 2010
Impax sued for patent infringement over generic Welchol

Impax confirmed a patent challenge for its version of a branded cholesterol drug that recently was submitted to the FDA for approval ...

November 22, 2010
Par begins shipping generic Accolate

WOODCLIFF LAKE, N.J. Par Pharmaceutical has begun shipments of a generic treatment for asthma, the drug maker said Monday.

Par announced that it started shipping zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a generic version of AstraZeneca’s Accolate.

Accolate has sales of $50 million in the United States per year, according to IMS Health.

November 21, 2010
Dr. Reddy’s launches generic Accolate

Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug...

November 21, 2010
FDA asks Xanodyne to pull painkillers from market

A drug maker will pull a common prescription painkiller from the market following the release...

November 18, 2010
Report: J&J subsidiary, government officials seek to block HIV generic

Johnson & Johnson and the U.S. government are suing two generic drug makers to stop...

November 15, 2010
Generic versions of Alimta, Abilify get shut down by district courts

The U.S. District Court for the District of Delaware has upheld a patent held by...

November 15, 2010
Hospira launches generic Gemzar

Generic injectable drug maker Hospira has launched a version of a chemotherapy drug, the company...

November 15, 2010
Impax gets FDA OK for generic Allegra-D

The Food and Drug Administration has approved a generic treatment made by Impax for seasonal...

November 15, 2010
Labopharm reviewing notification of Actavis' approval application for generic Oletpro

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...

November 15, 2010
NCPA voices support for new CMS rule shortening drug cycle for long-term care centers

The Centers for Medicare and Medicaid Services has proposed a rule shortening the traditional 30-day...

November 14, 2010
Biosimilars development continues emergence

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...

November 14, 2010
Countdown to 2011: A big year for generics

The world of generic drugs has a big year ahead of it. Actually, it has...

November 14, 2010
FDA generic user fees moving closer to reality

A backlog of more than 2,000 drug entities and devices is awaiting approval. That’s the...

November 14, 2010
GPhA responds to possibility of more stringent FDA regulations

A ghost from 2008 soon could come back to haunt 2010....

November 14, 2010
J&J announces results of phase-3 trial of rivaroxaban

An investigational drug made by Johnson & Johnson is more effective in reducing the risk...

November 14, 2010
Out-of-pocket costs vary widely for branded, generic drugs

The often wide gap between what consumers will pay out of pocket for a branded...

November 14, 2010
Patent cliff to bring short-term boon to generic industry

Look for a big surge in brand-to-generic drug switches at the pharmacy counter over the...

November 11, 2010
NACDS, NCPA claim pharmacy victory after withdrawal of Medicaid program provisions

The National Association of Chain Drug Stores and the National Community Pharmacists Association heralded the...

November 8, 2010
IMS Health executive: Generic competition can help U.S. save billions

Loss of patent protection for branded drugs and subsequent competition from generics could save the...

November 8, 2010
Report: Government officials question FDA's approval of generic Lovenox

Government officials said problems have arisen with the Food and Drug Administration’s approval of a...

© 2013 Drug Store News. All Rights Reserved.